Literature DB >> 29301919

A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma.

Imran Sulaiman1, Garrett Greene1, Elaine MacHale1, Jansen Seheult1, Matshediso Mokoka1, Shona D'Arcy2, Terence Taylor2, Desmond M Murphy3,4, Eoin Hunt3,4, Stephen J Lane5, Gregory B Diette6, J Mark FitzGerald7, Fiona Boland8, Aoife Sartini Bhreathnach1, Breda Cushen1, Richard B Reilly2,9,10, Frank Doyle8, Richard W Costello11,12.   

Abstract

In severe asthma, poor control could reflect issues of medication adherence or inhaler technique, or that the condition is refractory. This study aimed to determine if an intervention with (bio)feedback on the features of inhaler use would identify refractory asthma and enhance inhaler technique and adherence.Patients with severe uncontrolled asthma were subjected to a stratified-by-site random block design. The intensive education group received repeated training in inhaler use, adherence and disease management. The intervention group received the same intervention, enhanced by (bio)feedback-guided training. The primary outcome was rate of actual inhaler adherence. Secondary outcomes included a pre-defined assessment of clinical outcome. Outcome assessors were blinded to group allocation. Data were analysed on an intention-to-treat and per-protocol basis.The mean rate of adherence during the third month in the (bio)feedback group (n=111) was higher than that in the enhanced education group (intention-to-treat, n=107; 73% versus 63%; 95% CI 2.8%-17.6%; p=0.02). By the end of the study, asthma was either stable or improved in 54 patients (38%); uncontrolled, but poorly adherent in 52 (35%); and uncontrolled, but adherent in 40 (27%).Repeated feedback significantly improved inhaler adherence. After a programme of adherence and inhaler technique assessment, only 40 patients (27%) were refractory and adherent, and might therefore need add-on therapy.
Copyright ©ERS 2018.

Entities:  

Mesh:

Year:  2018        PMID: 29301919     DOI: 10.1183/13993003.01126-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  35 in total

1.  Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations.

Authors:  R Brett McQueen; Danielle N Sheehan; Melanie D Whittington; Job F M van Boven; Jonathan D Campbell
Journal:  Pharmacoeconomics       Date:  2018-08       Impact factor: 4.981

Review 2.  What can be done to impact respiratory inhaler misuse: exploring the problem, reasons, and solutions.

Authors:  Anna Volerman; Delesha Carpenter; Valerie Press
Journal:  Expert Rev Respir Med       Date:  2020-04-28       Impact factor: 3.772

3.  Controller Inhalers: Overview of Devices, Instructions for Use, Errors, and Interventions to Improve Technique.

Authors:  Patrick K Gleeson; Scott Feldman; Andrea J Apter
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03-12

4.  Integrating hospital and community care: using a community virtual ward model to deliver combined specialist and generalist care to patients with severe chronic respiratory disease in their homes.

Authors:  Breda Cushen; Aisling Madden; Deirdre Long; Yvonne Whelan; Michael Emmet O'Brien; Deirdre Carroll; Des O'Flynn; Michelle Forde; Virginia Pye; Loretto Grogan; Margaret Casey; Karolina Farrell; Richard W Costello; Clare Lewis
Journal:  Ir J Med Sci       Date:  2021-05-06       Impact factor: 2.089

5.  A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients.

Authors:  Alison Moore; Andrew Preece; Raj Sharma; Liam G Heaney; Richard W Costello; Robert A Wise; Andrea Ludwig-Sengpiel; Giselle Mosnaim; Jamie Rees; Ryan Tomlinson; Ruth Tal-Singer; David A Stempel; Neil Barnes
Journal:  Eur Respir J       Date:  2021-06-04       Impact factor: 33.795

Review 6.  The clinical impact of adherence to therapy in airways disease.

Authors:  Vincent Brennan; Christopher Mulvey; Richard W Costello
Journal:  Breathe (Sheff)       Date:  2021-06

Review 7.  Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers.

Authors:  Evalyne M Jansen; Susanne J van de Hei; Boudewijn J H Dierick; Huib A M Kerstjens; Janwillem W H Kocks; Job F M van Boven
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

8.  Con: Access to advanced therapies for severe asthma should be restricted to patients with satisfactory adherence to maintenance treatment.

Authors:  Ireti Adejumo; Dominick E Shaw
Journal:  Breathe (Sheff)       Date:  2021-06

Review 9.  Improving adherence in chronic airways disease: are we doing it wrongly?

Authors:  Gráinne d'Ancona; John Weinman
Journal:  Breathe (Sheff)       Date:  2021-06

10.  Safety of Once-Daily Single-Inhaler Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol in Japanese Patients with Asthma: A Long-Term (52-Week) Phase III Open-Label Study.

Authors:  Soichiro Hozawa; Hiroyuki Ohbayashi; Michiko Tsuchiya; Yu Hara; Laurie A Lee; Takashi Nakayama; Jun Tamaoki; Andrew Fowler; Takanobu Nishi
Journal:  J Asthma Allergy       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.